Global Digital Store – Ebooks and Softwares

Tag: Run

  • Simulating the stars at exascale requires HIP solutions

    Simulating the stars at exascale requires HIP solutions

    As GPU architectures have become the standard for scientific computing, application teams have had to retrofit their scientific codes to run on new systems. Even teams with codes that have been re-engineered for GPUs must continually adapt them for new architectures.

    Read More
    https://techxplore.com/news/2020-03-simulating-stars-exascale-requires-hip.html

    Views: 0

  • Autonomous on-demand buses underway in the streets of Europe

    Autonomous on-demand buses underway in the streets of Europe

    Would you like to take a ride on a driverless bus? This will be possible in five European cities between April and October 2020, where autonomous buses will be tested in real-life traffic conditions. Three international consortia have been awarded with contracts for the final phase of the pre-commercial procurement under the EU-funded FABULOS project. These consortia will pilot autonomous buses as part of the existing public transport systems. The initial tests will run in Gjesdal (Norway), Helsinki (Finland) and Tallinn (Estonia) in the spring and autumn. Pilots will also be launched in Lamia (Greece) and Helmond (the Netherlands).

    Read More

    Views: 0

  • High-quality extended reality in easy-to-use and inexpensive devices

    High-quality extended reality in easy-to-use and inexpensive devices

    Augmented reality (AR), virtual reality (VR), and mixed reality (MR) technology open new possibilities across many fields. However, high-quality extended reality (XR) applications are computationally heavy in terms of computer graphics, which means that they do not run smoothly on inexpensive and easy-to-use XR devices such as VR/AR headsets and smartphones, because their GPU computing capacity is limited.

    Read More

    Views: 0

  • End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo

    End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo

    Remarks by Dr Ibrahima Socé Fall, World Health Organization Assistant Director-General, Emergency Response

     

    Good afternoon. 

    I hope that your busy week was interrupted, like mine, with a moment of joy on Tuesday.

    That moment was the celebration of a woman being discharged from an Ebola treatment centre in Beni. Her name is Masiko.

    She was the last person in the Democratic Republic of the Congo confirmed to have Ebola.

    Health workers and other responders sacrificed a lot to get to this point. 

    Since the outbreak was declared in August 2018 there have been 420 attacks on health facilities in DRC, resulting in 11 deaths and 86 injuries among health care workers and patients.

    It’s been a huge amount of work. At the peak of the outbreak, more than 120 cases were being reported each week. 28 health zones were affected, with cases appearing 1200 kilometres apart. In response:

    • 11 labs have been set up to test around 3500 samples each week
    • 11 Ebola treatment centres were set up to care for people with Ebola
    • 300 000 people have been vaccinated
    • 250 000 contacts have been registered
    • 26 000 safe and dignified burials have been conducted
    • More than 3000 health facilities were identified for infection prevention and control support
    • More than 1000 metric tonnes of supplies have been delivered
    • An Ebola vaccine has been licensed, and two treatments found to be highly effective
    • Almost 160 000 million people have been screened for Ebola symptoms at borders or other points of control

    This work is continuing. The outbreak isn’t over. WHO recommends waiting two full incubation periods – that’s 42 days – after the last person tests negative a second time before declaring the end of the outbreak.

    We must stay in active response mode to get us over that finish line.

    We have to be prepared for other cases emerging. It’s is a very real risk.

    Remember that during the Ebola outbreak in West Africa flare-ups of new cases occurred after the end of the outbreak.

    There are four reasons why new cases may emerge during this 42-day period, or even after the end of the outbreak.

    • First, because of the complex security environment, Ebola transmission outside of groups under monitoring is possible.  
    • Second, Ebola virus can persist in used needles, syringes or vials for several weeks.
    • Third, Ebola virus can persist in the body fluids of survivors for many months, and can be transmitted well after recovery, or in rare cases can result in relapse – as we’ve already seen during this outbreak.
    • Finally, Ebola virus is present in an animal reservoir in the region, and there is always a risk of a new spillover to humans.

    This is why it’s critical to maintain surveillance and rapid response capacities.

    And that’s what we are doing. We’re still in full response mode.

    In addition to the activities I already mentioned, I have to underline how critical it is to continue supporting the Survivor Programme, which provides follow-up care for almost all of the 1169 survivors in 26 health areas in North Kivu and Ituri. The programme also helps reduce the risks of re-introduction events. 

    We need to continue this work until the end of the outbreak, to keep the capacity in place to rapidly respond to flare-ups, to keep supporting survivors after the outbreak, and to transition the capacities built in this response toward building a stronger health system. 

    But to be very frank, right now the world risks dropping the baton at the finish line. WHO faces an immediate US $20 million funding gap. If no new resources are received, we will run out of money before the end of the outbreak.

    We appreciate the generosity of donors who have supported the response since August 2018. Now we need to get over the finish line. WHO is calling on the international community to help us end this outbreak, and keep our promises to communities to build a stronger health system.

    If we are forced to scale back operations because of a lack of funds, and then a new case emerges, we might not have the people and resources on the ground that we need to shut down transmission quickly. Just a single case could re-ignite the epidemic.

    That would be a tragedy. An avoidable tragedy. 

    It is important that the global community doesn’t only focus efforts when there is an immediate threat, then walk away when the threat subsides.

    The health system has to be strong to stop much more than Ebola. It has to stop malaria, measles, cholera, and now COVID-19.

    There is a lot more work to do.

    Thank you.

     

    End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo
    Read More
    https://www.who.int/news-room/detail/06-03-2020-end-in-sight-but-flare-ups-likely-in-the-ebola-outbreak-in-the-democratic-republic-of-the-congo

    Views: 0

  • GM shows 13 electric vehicles as it tries to run with Tesla

    GM shows 13 electric vehicles as it tries to run with Tesla

    General Motors, trying to refashion itself as a futuristic company with technology to compete against Tesla, rolled out plans Wednesday for 13 new electric vehicles during the next five years.

    Read More

    Views: 0

  • The virtual paper-making machine of the future

    The virtual paper-making machine of the future

    A virtual paper-making machine makes it possible to test run and optimize operations without costly downtime in the industry. New research at Karlstad University saves money and spares the environment.

    Read More

    Views: 0

  • WHO steps up action to improve access to safe blood

    WHO steps up action to improve access to safe blood

    The World Health Organization’s new action plan to speed up universal access to safe blood and blood products pulls together existing recommendations and recommends new improved ways of working. It’s the start of a four-year collaborative effort to improve blood transfusion and blood-based therapies in all countries.

    Safe blood saves lives in all sorts of circumstances, not least in emergency and epidemic settings. Blood transfusion and blood products are critical for birth delivery for both the mother and baby; the survival and quality of life of patients suffering from life-threatening conditions such as haemophilia, thalassemia, immune deficiency and cancer; treating severe injuries and carrying out medical and surgical procedures.  

    But progress in blood safety and availability has been slow in many parts of the world, placing patients’ safety at risk and putting undue pressure on health workers. Progress is also mostly restricted to developed countries. Out of the approximate 118 million blood donations collected globally, 42% are collected in high-income countries, home to 16 % of the world’s population. And one out of four low-income countries do not test all donated blood, while 54% of countries do not have surveillance systems to securitise the supply chain from blood donor to patient. 

    Challenges include: slow implementation of national blood policies and weak blood regulatory systems; insufficient number of voluntary blood donors (who are considered the safest donors); poor quality management of screening tests, blood grouping and compatibility testing; inappropriate clinical use of blood; insufficient national funding for blood safety.

    To address these, WHO has set out six key objectives for all countries and in particular those with weak blood systems:

    • appropriately structured, well-coordinated and sustainably resourced national blood systems;
    • regulatory capacity to ensure the quality and safety of blood;
    • functioning and efficiently managed blood services;
    • effective implementation of patient blood management to optimize transfusion practices;
    • effective surveillance, haemovigilance and pharmacovigilance, supported by comprehensive and accurate data collection systems;
    • partnerships, collaboration and information exchange to achieve key priorities and jointly address challenges and emerging threats at global, regional and national levels.

    The Organization looks forward to working with partners worldwide to implement the plan, improve blood supply particularly in the low and middle-income countries where this is so urgently needed, and save lives. The plan will run from 2020-2024.

    WHO steps up action to improve access to safe blood
    Read More
    https://www.who.int/news-room/detail/26-02-2020-who-steps-up-action-to-improve-access-to-safe-blood

    Views: 0

  • WHO and FIND formalize strategic collaboration to drive universal access to essential diagnostics

    Geneva, Switzerland – 10 February 2020 – The World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced today that a memorandum of understanding has been signed by the two organizations to formalize a strategic collaboration that will strengthen diagnosis in resource-poor countries by closing major diagnostic gaps at country level and bolstering disease surveillance that will inform public health initiatives and enhance outbreak preparedness and response.

    “This collaboration is an inspiring development that will take us a long way towards ensuring access to diagnostics to all who need them,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “Global health challenges such as the ongoing novel coronavirus (2019-nCoV) outbreak demonstrates that without these essential elements of health systems, we cannot hope to promote health, keep the world safe, and serve the vulnerable. I look forward to working closely with FIND to determine what countries need and to forge a path to deliver these innovations so that no one is left behind.”

    Diagnosis is a driver of patient, financial and health systems impact, and a critical enabler of universal health coverage, but it is also the weakest link in the care cascade. This is especially true in primary healthcare settings in low- and middle-income countries. A unique and unprecedented opportunity exists to expand the role and impact of diagnostics to fully realize their potential to address major health security threats and evolving disease burdens through technological and digital advances.

    FIND has been an active partner with WHO since 2008 and a WHO Collaborating Centre since 2014, acting in the areas of laboratory strengthening and diagnostic technology evaluation. This expanded collaboration will put in place the building blocks necessary to enable transformative change in a move toward a country-led diagnostics alliance. Initial workstreams will focus on demand-driven access to essential diagnostics and the development of national Essential Diagnostics Lists, alongside collection of data that assist the scale up of diagnostics to support low- and middle-income countries on their paths to universal health coverage.

    “Each and every person has the right to a quality, timely diagnosis,” said Catharina Boehme, CEO of FIND. “Comprehensive diagnostic services underpin functional and efficient health systems not only to manage day-to-day healthcare needs, but also to ensure new disease outbreaks can be spotted and contained quickly. Working closely with WHO as part of a country-led alliance, we will strive to ensure that low- and middle-income countries have what they need to develop their own comprehensive, data-driven diagnostic strategies that enable universal health coverage and empower disease surveillance. Our ambition is that all patients, providers and decision-makers have access to the diagnostic solutions needed for optimal health outcomes.”

    The strategic collaboration agreement will initially run for a period of 5 years, until 2025.

    #  #  #

    About FIND

    FIND is a global non-profit organization that drives innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations. Our work bridges R&D to access, overcoming scientific barriers to technology development; generating evidence for regulators and policy-makers; addressing market failures; and enabling accelerated uptake and access to diagnostics in low- and middle-income countries (LMICs). Since 2003, we have been instrumental in the development of 24 new diagnostic tools used in 150 LMICs. Over 50 million FIND-supported products have been provided to our target markets since the start of 2015. A WHO Collaborating Centre, we work with more than 200 academic, industry, governmental, and civil society partners worldwide, on over 70 active projects that cross six priority disease areas. FIND is committed to a future in which diagnostics underpin treatment decisions and provide the foundation for disease surveillance, control and prevention. For more information, please visit www.finddx.org

     

    About WHO

    The World Health Organization is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. WHO is committed to the enjoyment of the highest attainable standard of health as one of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition. WHO’s current global programme of work sets out three interconnected strategic priorities: ensuring healthy lives and well-being for all at all ages; achieving universal health coverage; and addressing health emergencies and promoting healthier populations. These priorities are linked to three ambitious targets, the “triple billion”: one billion more people to benefit from universal health coverage; one billion more people better protected from health emergencies; and one billion more people enjoying better health and well-being.

     

    Read More
    https://www.who.int/news-room/detail/10-02-2020-who-and-find-formalize-strategic-collaboration-to-drive-universal-access-to-essential-diagnostics

    Views: 0

  • Renfe inks $6 bn deal to build high-speed train in US

    Renfe inks $6 bn deal to build high-speed train in US

    Spanish train operator Renfe on Thursday said it had signed a $6-billion deal with US rail developer Texas Central to design, build and run a high-speed rail line in the United States.

    Views: 0

  • How to Make Money Fast by Retrieving and Returning Shopping Carts

    [ad_1]

    Are you looking for a way to make money fast? If you have a large utility vehicle, like a pick-up truck, you can retrieve and return shopping carts for a cash reward.

    Most every mid to large retail grocery, variety and department store has a stock of shopping carts on hand. They are purchased by the store, of course, so that customers can use them when shopping in their store.

    Shopping buggies are expensive. The average cost to the retailer for just one is between 75 and 100 dollars. Large ones like the kind you find at wholesale and club stores can run upwards of 200 dollars or more.

    Most retail stores have dozens of them; busy big-box stores may even have hundreds of them. Purchasing enough of them to meet a store’s demand and traffic levels requires a significant expenditure of cash.

    It is, therefore, in the best interest of the retailer to protect that investment. Most retailers do their best to make sure that carts remain on store property. However, shopping buggy theft is all too common. The average store loses about $8,000 $10,000 to per year to this problem.

    Because they are so expensive to buy, many store owners and retail companies pay cash rewards for the return of their carts which have been stolen (or “borrowed”) and not returned. Cash rewards typically range from 25 to 50 dollars per cart.

    Here’s how you can retrieve and return those buggies for cash: contact retailers in your area which have shopping carts. Find out if they pay for returned carts. Many do, but won’t give cash rewards to just anyone. (Store owners don’t want the public to abuse the reward system by stealing carts themselves in order to get the reward.) Usually you have to sign a cash-for-retrieval contract.

    You’ll have to provide some forms of identification, usually a driver’s license plus one other item (like a Social Security or credit card). You may have to sign a waiver absolving the store of liability in the event of something unforeseen.

    You can make arrangements with any or all of the retailers in your area. The more contracts you have, the more money you can make.

    If you’ve lived in your city for any length of time, you’ve probably seen common dump sites for stolen shopping buggies. Visit these areas regularly. Additionally, get in the habit of keeping your eyes open every time you’re out and about town. You’ll probably spot discarded shopping carts regularly. You can pick these up and return them as you come across them, or store them at home until you have several of them.

    [ad_2]

    Source by Scott Lindsay

    Views: 0